Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1999 1
2000 2
2001 4
2002 2
2003 5
2004 3
2005 6
2006 3
2007 3
2008 5
2009 5
2010 1
2011 4
2012 3
2013 4
2014 5
2015 3
2016 1
2017 3
2018 3
2019 3
2020 3
2021 3
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 19773400

75 results

Results by year

Filters applied: . Clear all
Page 1
Is DHEA replacement beneficial in chronic adrenal failure?
Lang K, Burger-Stritt S, Hahner S. Lang K, et al. Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):25-32. doi: 10.1016/j.beem.2014.09.007. Epub 2014 Oct 2. Best Pract Res Clin Endocrinol Metab. 2015. PMID: 25617170 Review.
Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
Binder G, Weber S, Ehrismann M, Zaiser N, Meisner C, Ranke MB, Maier L, Wudy SA, Hartmann MF, Heinrich U, Bettendorf M, Doerr HG, Pfaeffle RW, Keller E; South German Working Group for Pediatric Endocrinology. Binder G, et al. J Clin Endocrinol Metab. 2009 Apr;94(4):1182-90. doi: 10.1210/jc.2008-1982. Epub 2009 Jan 6. J Clin Endocrinol Metab. 2009. PMID: 19126625 Clinical Trial.
Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial.
van Thiel SW, Romijn JA, Pereira AM, Biermasz NR, Roelfsema F, van Hemert A, Ballieux B, Smit JW. van Thiel SW, et al. J Clin Endocrinol Metab. 2005 Jun;90(6):3295-303. doi: 10.1210/jc.2004-1802. Epub 2005 Mar 29. J Clin Endocrinol Metab. 2005. PMID: 15797966 Clinical Trial.
Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
Christiansen JJ, Andersen NH, Sørensen KE, Pedersen EM, Bennett P, Andersen M, Christiansen JS, Jørgensen JO, Gravholt CH. Christiansen JJ, et al. Clin Endocrinol (Oxf). 2007 Mar;66(3):426-33. doi: 10.1111/j.1365-2265.2007.02750.x. Clin Endocrinol (Oxf). 2007. PMID: 17302879 Clinical Trial.
Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis.
Elraiyah T, Sonbol MB, Wang Z, Khairalseed T, Asi N, Undavalli C, Nabhan M, Altayar O, Prokop L, Montori VM, Murad MH. Elraiyah T, et al. J Clin Endocrinol Metab. 2014 Oct;99(10):3536-42. doi: 10.1210/jc.2014-2261. J Clin Endocrinol Metab. 2014. PMID: 25279571 Free PMC article. Review.
DHEA: the last elixir.
[No authors listed] [No authors listed] Prescrire Int. 2002 Aug;11(60):118-23. Prescrire Int. 2002. PMID: 12199273
75 results